Key result
Higher TG/RC lipid phenotype is linked to ~37% higher odds of diabetic kidney disease.
Why the study?
This study aimed to identify lipid phenotypes integrating traditional and nontraditional lipid parameters and examine their associations with diabetic kidney disease.
Does a higher triglycerides/remnant cholesterol lipid phenotype increase the odds of diabetic kidney disease in Chinese adults with type 2 diabetes mellitus?
Observational (n=4,936)
Yes
Does a higher triglycerides/remnant cholesterol lipid phenotype increase the odds of diabetic kidney disease in Chinese adults with type 2 diabetes mellitus?
Integrating traditional and nontraditional lipid measures via clustering identifies a high-TG/RC phenotype strongly associated with diabetic kidney disease, especially when combined with elevated C-reactive protein, supporting more targeted renal risk assessment in type 2 diabetes.
Answers are grounded in this paper and cite their sources.
Association of TG/RC phenotype with DKD should not change practice; hypothesis-generating and leaves causal role open for prospective study.
BACKGROUND: This study aimed to identify lipid phenotypes integrating traditional and nontraditional lipid parameters and examine their associations with diabetic kidney disease (DKD). METHODS: The study analyzed 4,936 Chinese adults with type 2 diabetes mellitus recruited from 24 primary medical institutions. K-means clustering was performed using triglycerides (TG), high-density lipoprotein cholesterol (HDL), low-density lipoprotein cholesterol (LDL), atherogenic index of plasma, and remnant cholesterol (RC). Multivariable logistic regression was used to evaluate associations between lipid phenotypes and DKD and interactions with C-reactive protein were assessed on multiplicative and additive scales. The higher TG/RC phenotype exhibited more severe metabolic-inflammatory status and a higher prevalence of DKD than the other phenotype (52.44% vs 44.00%). After full adjustment, the higher TG/RC phenotype was associated with higher odds of DKD (OR 1.370, 95% CI 1.172-1.602), early DKD (OR 1.238, 95% CI 1.059-1.446), and reduced eGFR (OR 2.062, 95% CI 1.420-2.994). Participants with both the higher TG/RC phenotype and elevated C-reactive protein levels showed the highest odds of DKD (OR 1.881, 95% CI 1.540-2.297), with significant multiplicative and additive interactions. The clustered phenotype also provided incremental discriminative information beyond individual lipid markers, and the findings remained consistent across sensitivity analyses. CONCLUSIONS: Integrating traditional and nontraditional lipid measures may help identify clinically relevant lipid phenotypes associated with DKD and support more targeted renal assessment in T2DM patients.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) conducted an observational in Type 2 diabetes mellitus and diabetic kidney disease (n=4,936). Higher TG/RC lipid phenotype vs. Other lipid phenotype was evaluated on Diabetic kidney disease (DKD) (OR 1.370, 95% CI 1.172-1.602). The higher TG/RC lipid phenotype was associated with higher odds of diabetic kidney disease compared with the other phenotype (52.44% vs 44.00%; OR 1.370, 95% CI 1.172-1.602).
Synapse has enriched 10 related papers. Consider them for comparative context: